Elikya Therapeutics
PrivateCompany Overview
Elikya Therapeutics operates in Healthcare & Life Sciences and is based in Strasbourg. It was founded in 2021.
Elikya Therapeutics is a biotechnology company that develops next-generation antibody-drug conjugates (ADCs) with first-in-class toxic payloads for oncology treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elikya Therapeutics Comparables
Compare Elikya Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seekyo | 87% | |
| Eli Lilly and Company | 82% | |
| Phrontline Biopharma | 81% |
For institutional investors. Book with your work email.
Elikya Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Elikya Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Landmark BioVentures AG | Seed |
| SEMIA | Seed |
| SATT Paris-Saclay | Seed |
| Bpifrance | Grant |
Elikya Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elikya Therapeutics's valuation, stock price, and market status.
Is Elikya Therapeutics a public or private company?
Elikya Therapeutics is a private company.
What is the current stock price of Elikya Therapeutics?
Elikya Therapeutics is a private company, so its shares have no public market price. Caplight tracks Elikya Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elikya Therapeutics worth (valuation)?
Valuation information for Elikya Therapeutics is not publicly available.
Can I buy Elikya Therapeutics stock?
Elikya Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elikya Therapeutics's last funding round?
Funding round information for Elikya Therapeutics is not publicly available.
Who are the main investors in Elikya Therapeutics?
Key investors in Elikya Therapeutics include Landmark BioVentures AG, SEMIA, SATT Paris-Saclay, Bpifrance.
Will Elikya Therapeutics IPO soon?
No public IPO plans have been announced for Elikya Therapeutics.
How can I track Elikya Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Elikya Therapeutics's shares on secondary markets.